Sunder Biomedical Tech Co

Sunder Biomedical Tech Co Operating Cash Flow

The Operating Cash Flow of Sunder Biomedical Tech Co (4115.TWO) as of Oct 30, 2026 is 70.59 M TWD. In the previous year, Operating Cash Flow was 108.13 M TWD — a change of -34.72% (lower).

Operating Cash Flow

70.59 MTWD

YoY

-34.72%

Last updated:

Operating Cash Flow of Sunder Biomedical Tech Co is 2025 70.59 M TWD. Operating Cash Flow of Sunder Biomedical Tech Co was 2024 108.13 M TWD. It decreases by -34.72% lower compared to the previous year.

The Sunder Biomedical Tech Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2020
104.75 M TWD
Jan 1, 2021
177.86 M TWD
Jan 1, 2022
104.42 M TWD
Jan 1, 2023
47.41 M TWD
Jan 1, 2024
108.13 M TWD
Jan 1, 2025
70.59 M TWD
The Sunder Biomedical Tech Co Operating Cash Flow history
YEAROperating Cash FlowYoY
70.59 MTWD-34.72%
108.13 MTWD+128.08%
47.41 MTWD-54.60%
104.42 MTWD-41.29%
177.86 MTWD+69.80%
104.75 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunder Biomedical Tech Co Stock analysis

What does Sunder Biomedical Tech Co do? Sunder Biomedical Tech Co Ltd manufactures and sells medical consumables including blood circuit catheters, puncture needles, infusion sets, suction tubing, dosing sets, waste fluid collection bags, and protective covers. The company also produces laparoscopic smoke filters, suction sets, pick-up bags, and medical grade materials such as PVC pellets, NON-diethylhexyl phthalate (DEHP) PVC, and other medical components. Additionally, Sunder Biomedical offers sterilization and laboratory services, along with foundry services for masks, tubes, and nucleic acid extraction well tray consumables. The primary buyers of Sunder Biomedical's products are healthcare facilities, hospitals, and medical institutions requiring disposable medical equipment and supplies. These clients purchase medical consumables for routine procedures, surgical operations, and patient care. The company's focus on medical grade materials ensures compliance with healthcare standards, making its products essential for medical professionals. Sunder Biomedical's revenue streams include direct sales of medical consumables, sterilization services, and foundry services for specialized medical components. The company targets the healthcare sector, particularly hospitals and clinics, where demand for reliable, high-quality disposable medical products is consistent. By providing a comprehensive range of medical supplies, Sunder Biomedical caters to the operational needs of healthcare providers across various medical specialties. Sunder Biomedical Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunder Biomedical Tech Co stock

Operating Cash Flow of Sunder Biomedical Tech Co is 70.59 M TWD in 2025.

Operating Cash Flow of Sunder Biomedical Tech Co changed from 108.13 M TWD to 70.59 M TWD, representing a -34.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Sunder Biomedical Tech Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Sunder Biomedical Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Sunder Biomedical Tech Co

All Key Metrics — Sunder Biomedical Tech Co